Filed: 8/13/2025ACC: 0001999371-25-011256
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 88 equity positions with a total reported market value of $732.19M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
88
Positions
$732.19M
Total AUM (reported)
92.92M
Total Shares
Allocation by class
COM$404.79M55.3%
SPONSORED ADS$93.92M12.8%
SHS$49.40M6.7%
COM PAR $.01$47.80M6.5%
COM NEW$33.90M4.6%
COMMON STOCK$32.60M4.5%
CL A$12.84M1.8%
Portfolio Concentration
Top 3$139.93M19.1%
4–10$205.84M28.1%
11–25$207.82M28.4%
Rest$178.61M24.4%
Top 3 weight
19.1%
Top 10 weight
47.2%
Voting Authority Distribution
Total shares with voting rights: 92.92M
Sole
Full voting authority
92.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole88
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings88
Rows:
VERONA PHARMA PLC
SOLEShares610K
TypeSH
Market value$57.69M
7.88%
Sole
610K
Shared
0.00
None
0.00
INSMED INC
SOLEShares475K
TypeSH
Market value$47.80M
6.53%
Sole
475K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$34.43M
4.70%
Sole
1.10M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares495K
TypeSH
Market value$32.60M
4.45%
Sole
495K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares250K
TypeSH
Market value$32.05M
4.38%
Sole
250K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares415K
TypeSH
Market value$31.66M
4.32%
Sole
415K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares694.40K
TypeSH
Market value$30.16M
4.12%
Sole
694.40K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1M
TypeSH
Market value$28.61M
3.91%
Sole
1M
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares600K
TypeSH
Market value$26.45M
3.61%
Sole
600K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares440K
TypeSH
Market value$24.32M
3.32%
Sole
440K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares80K
TypeSH
Market value$24.21M
3.31%
Sole
80K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.40M
TypeSH
Market value$23.46M
3.20%
Sole
1.40M
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares3.59M
TypeSH
Market value$14.43M
1.97%
Sole
3.59M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares970K
TypeSH
Market value$14.36M
1.96%
Sole
970K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares334.86K
TypeSH
Market value$14.30M
1.95%
Sole
334.86K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.53M
TypeSH
Market value$13.86M
1.89%
Sole
2.53M
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares2M
TypeSH
Market value$13.00M
1.78%
Sole
2M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares545K
TypeSH
Market value$12.84M
1.75%
Sole
545K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares900K
TypeSH
Market value$12.18M
1.66%
Sole
900K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares900.16K
TypeSH
Market value$11.83M
1.62%
Sole
900.16K
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares15.25M
TypePRN
Market value$11.62M
1.59%
Sole
15.25M
Shared
0.00
None
0.00
AMGEN INC
SOLEShares40K
TypeSH
Market value$11.17M
1.53%
Sole
40K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares967.62K
TypeSH
Market value$11.02M
1.51%
Sole
967.62K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares2.20M
TypeSH
Market value$9.81M
1.34%
Sole
2.20M
Shared
0.00
None
0.00
CRISPR Therapeutics AG
SOLEShares200K
TypeSH
Market value$9.73M
1.33%
Sole
200K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERONA PHARMA PLCSOLE | SPONSORED ADS | 610K | SH | $57.69M 7.88% | 610K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 475K | SH | $47.80M 6.53% | 475K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $34.43M 4.70% | 1.10M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 495K | SH | $32.60M 4.45% | 495K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 250K | SH | $32.05M 4.38% | 250K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 415K | SH | $31.66M 4.32% | 415K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 694.40K | SH | $30.16M 4.12% | 694.40K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 1M | SH | $28.61M 3.91% | 1M | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 600K | SH | $26.45M 3.61% | 600K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 440K | SH | $24.32M 3.32% | 440K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 80K | SH | $24.21M 3.31% | 80K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.40M | SH | $23.46M 3.20% | 1.40M | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 3.59M | SH | $14.43M 1.97% | 3.59M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 970K | SH | $14.36M 1.96% | 970K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 334.86K | SH | $14.30M 1.95% | 334.86K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.53M | SH | $13.86M 1.89% | 2.53M | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 2M | SH | $13.00M 1.78% | 2M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 545K | SH | $12.84M 1.75% | 545K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 900K | SH | $12.18M 1.66% | 900K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 900.16K | SH | $11.83M 1.62% | 900.16K | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | NOTE 3.000%10/1 | 15.25M | PRN | $11.62M 1.59% | 15.25M | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 40K | SH | $11.17M 1.53% | 40K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 967.62K | SH | $11.02M 1.51% | 967.62K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 2.20M | SH | $9.81M 1.34% | 2.20M | 0.00 | 0.00 |
CRISPR Therapeutics AGSOLE | COM | 200K | SH | $9.73M 1.33% | 200K | 0.00 | 0.00 |
Page 1 of 4